Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FKKN5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,525
Award facts
- Contract value 100% obligated
- $33,525.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $33,525.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The award, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, carries no set-aside designation, indicating the contractor won this requirement through unrestricted competition. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036.
DMS Pharmaceutical Group has demonstrated substantial performance across the Defense Logistics Agency's medical supply chain, supplying a diverse portfolio of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. The PPV-G GEN V represents a critical modernization of the military pharmaceutical supply chain, enabling the agency to procure firm fixed-price delivery orders for branded and generic prescription drugs, biologics, vaccines, and specialized medical products. Under this contract vehicle, DMS Pharmaceutical Group serves as a regional prime vendor contractor supporting recurring medical supply needs for military healthcare facilities worldwide, with this Nexplanon implant delivery order exemplifying the contractor's role in providing specialized pharmaceutical products essential to DoD medical operations.
Quick answers
Who was awarded contract SPE2DR26FKKN5?
SPE2DR26FKKN5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FKKN5 worth?
The government has obligated $33,525 on SPE2DR26FKKN5.
Is contract SPE2DR26FKKN5 an order under another contract?
Yes. SPE2DR26FKKN5 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKN5 competed?
The extent of competition for SPE2DR26FKKN5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award